UnitedHealth independent‑chair vote
- Shareholders will vote on a proposal requiring any future UnitedHealth board chair to be independent. - UnitedHealth reported Q1 net earnings of $6.48 billion and revenue of $111.7 billion. - The company opposes the proposal and is urging investors to vote against it, signalling an active governance debate on board structure. (finance.yahoo.com)
Shareholders will vote on a proposal that would require any future UnitedHealth Group board chair to be an independent director. (finance.yahoo.com) The proposal was filed by the nonprofit Accountability Board and was first publicly lodged in October 2025. (marketscreener.com) UnitedHealth reported first‑quarter 2026 net earnings of $6.48 billion and consolidated revenues of $111.7 billion in its April 21, 2026 results. (news.ambest.com) The company’s proxy materials show the board is urging investors to vote AGAINST the independent‑chair measure and recommends voting against the proposal. (quartr.com) The governance fight follows Stephen Hemsley’s return to the CEO role and his retention of the board chair post after Andrew Witty’s surprise resignation in May 2025. (healthcaredive.com) The Accountability Board asks shareholders to amend UnitedHealth’s bylaws to require any future chair be independent, arguing the combined CEO/chair role concentrates power and weakens oversight. (fiercehealthcare.com) Votes must be submitted before the proxy deadlines (May 31, 2026 for most holders) ahead of UnitedHealth’s annual meeting on June 1, 2026, when the company will tally the outcome. (ebs.publicnow.com)